Marvin Slosman Email

CEO . InspireMD

Current Roles

Employees:
97
Revenue:
$13.6M
About
InspireMD is a commercial-stage medical device company with proprietary and innovative stent designs with integrated embolic prevention systems (EPS) designed for delivering neurovascular protection and stroke prevention. \nInspireMD is dedicated to the development of advanced technologies and seeks to utilize its proprietary MicroNet™ technology to make its products the industry standard for treatment of carotid artery disease by providing outstanding acute results and durable stroke free long-term outcomes through a proprietary stent platform, CGuard™ EPS.\nCGuard brings to the world the only carotid stent platform with patented MicroNet™ mesh technology designed to reduce stroke during and after CAS.\nInspireMD (NSPR) is traded on NASDQ Capital Markets.
InspireMD Address

Miami, FL
IL
InspireMD Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.